Purification and antioxidant properties of bigeye tuna (Thunnus obesus) dark muscle peptide on free radical-mediated oxidative systems.
ABSTRACT To produce bioactive peptides from by-products of fish processing, bigeye tuna dark muscle was hydrolyzed using various enzymes (alcalase, alpha-chymotrypsin, neutrase, papain, pepsin, and trypsin), and the hydrolysates were evaluated for antioxidant activity. Considering the results of degree of hydrolysis and antioxidant activities, peptic hydrolysate was used for further studies to identify a potent antioxidant peptide. Antioxidant peptide was purified using consecutive chromatographic methods and was identified as being H-Leu-Asn-Leu-Pro-Thr-Ala-Val-Tyr-Met-Val-Thr-OH (MW 1,222 Da) by quantitative time-of-flight electrospray ionization mass spectrometry. Purified antioxidant peptide from bigeye tuna dark muscle (APTDM) was investigated for its antioxidant activities using both free radical scavenging effects and polyunsaturated fatty acid (PUFA) peroxidation inhibitory activity. The results showed that APTDM effectively quenched with low 50% inhibitory concentration values compared to vitamin C as a positive control against four different free radicals: 1,1-diphenyl-2-picrylhydrazyl, hydroxyl, superoxide, and alkyl radical. APTDM also inhibited PUFA peroxidation in a linoleic acid emulsion system, and the activity was similar to that of alpha-tocopherol. We further investigated its antioxidant activities on cellular systems, and the results showed that APTDM significantly scavenged cellular radicals and enhanced the viability of tert-butyl hydroperoxide-induced cytotoxicity. These results indicate that APTDM or a peptide fraction containing APTDM would be a beneficial ingredient for functional food and/or pharmaceuticals.
Article: Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry.[show abstract] [hide abstract]
ABSTRACT: Hypertension or high blood pressure is one of the major independent risk factors for cardiovascular diseases. Angiotensin-I-converting enzyme (EC 22.214.171.124; ACE) plays an important physiological role in regulation of blood pressure by converting angiotensin I to angiotensin II, a potent vasoconstrictor. Therefore, the inhibition of ACE activity is a major target in the prevention of hypertension. Recently, the search for natural ACE inhibitors as alternatives to synthetic drugs is of great interest to prevent several side effects and a number of novel compounds such as bioactive peptides, chitooligosaccharide derivatives (COS) and phlorotannins have been derived from marine organisms as potential ACE inhibitors. These inhibitory derivatives can be developed as nutraceuticals and pharmaceuticals with potential to prevent hypertension. Hence, the aim of this review is to discuss the marine-derived ACE inhibitors and their future prospects as novel therapeutic drug candidates for treat hypertension.Marine Drugs 01/2010; 8(4):1080-93. · 3.85 Impact Factor